GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/Ultraprocessed Food and Premature Death
93

Ultraprocessed Food and Premature Death

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated October 1, 2025

Ultraprocessed foods (UPFs) have been linked to higher rates of premature death, according to a global analysis conducted across eight countries. The study highlights a clear dose–response pattern: for every 10% increase in daily energy intake from UPFs, the risk of all-cause mortality rises by 2.7%. This finding underscores the significant health risks associated with diets high in UPFs.

Key Findings:

  1. Country Variations in UPF Consumption:
  • The proportion of UPFs in daily diets varies widely across countries. For instance, Colombia has the lowest share, with UPFs contributing 15% of daily caloric intake, while the United States has the highest, exceeding 50%.
  • This variation in consumption directly correlates with the estimated premature deaths attributable to UPFs. In Colombia, 4% of premature deaths were linked to UPFs, whereas in the US and UK, the figure reached 14%.
  1. Impact on Premature Deaths:
  • In the United States alone, UPFs were estimated to contribute to 124,000 premature deaths in 2018.
  • These findings highlight the significant burden of UPF consumption on public health.
  1. What Are UPFs?:
  • Ultraprocessed foods are industrial formulations that typically contain little to no whole food content. They are often high in unhealthy ingredients such as fats, sugars, and additives.
  • Examples include sugary drinks, packaged snacks, instant meals, and fast food.
  1. Public Health Implications:
  • Researchers have declared UPFs a "public health concern" and emphasized the need for policy interventions beyond individual education.
  • Suggested measures include:
  • Taxes on UPFs to discourage consumption.
  • Subsidies for fresh and whole foods to make healthier options more accessible.
  • Improved labeling to help consumers identify and avoid UPFs.
  • Restrictions on marketing to limit the promotion of UPFs, particularly to vulnerable populations like children.
  1. Study Limitations:
  • The analysis relied on observational data and broad NOVA food categories, which classify foods based on their level of processing.
  • While this introduces some limitations, the consistency of findings across multiple countries strengthens the argument that UPFs are detrimental to health.

Global Health Priority:

The study’s findings make a compelling case for reducing UPF intake as a global health priority. The widespread consumption of UPFs, especially in countries like the US and UK, poses a significant challenge to public health systems. Addressing this issue will require coordinated efforts from governments, health organizations, and the food industry to implement effective policies that promote healthier diets and reduce the prevalence of UPFs in food systems.

Related Q&A

94

Obesity and Gut Microbiota

Obesity and gut microbiota are intricately linked, as the microbial composition and functions in the gut play a significant role in energy balance, metabolism, and fat storage. The...

95

DGBI and Carbohydrate intolerance

Disorders of Gut-Brain Interaction (DGBI) and Carbohydrate Intolerance: Overview of DGBI: Disorders of Gut-Brain Interaction (DGBI) encompass a group of conditions characterized by abnormal communication between the gut...

96

Auto-Brewery Syndrome (ABS)

Auto-Brewery Syndrome (ABS), also referred to as gut fermentation syndrome, is a rare and likely underdiagnosed medical condition in which gut microbes (bacteria and/or yeast) ferment carbohydrates into...

97

Extra bacterial Gut Ecosystem

The gut ecosystem is predominantly composed of bacteria, but emerging research highlights the importance of other microbial entities, such as fungi and bacteriophages, which play crucial roles in...

98

Obefazimod (ABX464) in Ulcerative Colitis

Obefazimod, also known as ABX464, is a first-in-class small molecule with a novel mechanism of action specifically designed to treat moderate-to-severe ulcerative colitis (UC). Below is a detailed...

99

Binge Eating Disorder (BED)

Binge Eating Disorder (BED) is a serious and common eating disorder characterized by recurrent episodes of consuming large quantities of food in a short period, often accompanied by...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer